Patents by Inventor Louis-David Cantin

Louis-David Cantin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20230406851
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 26, 2023
    Publication date: December 21, 2023
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20220062290
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: November 10, 2021
    Publication date: March 3, 2022
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20210228588
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: April 8, 2021
    Publication date: July 29, 2021
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20200390779
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: August 27, 2020
    Publication date: December 17, 2020
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20200138826
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 7, 2020
    Publication date: May 7, 2020
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20190231789
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: April 4, 2019
    Publication date: August 1, 2019
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20190030040
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: February 27, 2018
    Publication date: January 31, 2019
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Imidazopyridine compounds and uses thereof
    Patent number: 9937185
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: April 10, 2018
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20180015099
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: September 26, 2017
    Publication date: January 18, 2018
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Imidazopyridine compounds and uses thereof
    Patent number: 9814725
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processesor making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: November 14, 2017
    Assignee: NEOMED INSTITUTE
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Imidazopyridine Compounds and Uses Thereof
    Publication number: 20170143730
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: February 2, 2017
    Publication date: May 25, 2017
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Imidazopyridine compounds and uses thereof
    Patent number: 9598409
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: March 21, 2017
    Assignee: Neomed Institute
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Imidazopyridine Compounds and Uses Thereof
    Publication number: 20150361078
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 17, 2015
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • NOVEL SULFONATE-BASED TRIMEBUTINE SALTS
    Publication number: 20150057316
    Abstract: The present description relates to compounds of Formula I (A+ X?), a diastereoisomer, an enantiomer, or a mixture thereof, pharmaceutical composition comprising same and uses thereof for gastrointestinal endoscopic and medical imaging applications, and for the treatment of visceral pain: Where R1 and R2 are as defined herein
    Type: Application
    Filed: March 11, 2013
    Publication date: February 26, 2015
    Inventors: Jean-Francois Meunier, Cheuk Kun Lau, Daniel Guay, Gregory Bydlinski, Nadejda Spassova, Louis-David Cantin, Maxime Ranger
  • Benzoimidazole compounds and uses thereof
    Patent number: 8530467
    Abstract: This invention generally relates to substituted benzoimidazole compounds, particularly methyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: September 10, 2013
    Assignee: Neomed Institute
    Inventors: Louis-David Cantin, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Benzoimidazole Compounds and Uses Thereof
    Publication number: 20120289504
    Abstract: This invention generally relates to substituted benzoimidazole compounds, particularly methyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: May 16, 2012
    Publication date: November 15, 2012
    Applicant: ASTRAZENECA AB
    Inventors: Louis-David Cantin, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • UREA COMPOUNDS USEFUL IN THE TREATMENT OF CANCER
    Publication number: 20110195110
    Abstract: Pyrazole urea compounds, pharmaceutical compositions which contain them and methods for treating cancer using them.
    Type: Application
    Filed: December 1, 2006
    Publication date: August 11, 2011
    Inventors: Roger Smith, Holia N. Hatoum-Mokdad, Louis David Cantin, Donald E. Bierer, Wenlang Fu, Dhanapalan Nagarathnam, Gaetan Ladouceur, Yamin Wang, Herbert Ogutu, Scot Wilhelm, Ian Taylor, Sanjeeva Reddy, Richard Gedrich, Christopher Carter, Aaron Schmitt, Xiaomei Zhang
  • Indole acetic acid derivatives and their use as pharmaceutical agents
    Patent number: 7964622
    Abstract: This invention is directed to indole acetic acid derivatives and their use in pharmaceutical compositions for the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease. The invention is also directed to intermediates useful in preparation of indole acetic derivatives and to methods of preparation.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: June 21, 2011
    Assignee: Bayer Healthcare LLC
    Inventors: Xin Ma, Louis-David Cantin, Soongyu Choi, Roger Clark, Martin Hentemann, Joachim Rudolph, Rico Lavoie, Zhonghua Zhang
  • Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
    Patent number: 7906653
    Abstract: This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.
    Type: Grant
    Filed: April 13, 2010
    Date of Patent: March 15, 2011
    Assignee: Bayer Healthcare LLC
    Inventors: Louis-David Cantin, Soongyu Choi, Roger B. Clark, Martin F. Hentemann, Xin Ma, Joachim Rudolph, Sidney X. Liang, Christiana Akuche, Rico C. Lavoie, Libing Chen, Dyuti Majumdar, Philip L. Wickens
  • Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
    Publication number: 20100204472
    Abstract: This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.
    Type: Application
    Filed: April 13, 2010
    Publication date: August 12, 2010
    Inventors: Louis-David Cantin, Soongyu Choi, Roger B. Clark, Martin F. Hentemann, Xin Ma, Joachim Rudolph, Sidney X. Liang, Christiana Akuche, Rico C. Lavoie, Libing Chen, Dyuti Majumdar, Philip L. Wickens